Regulatory Submissions & Translation Management

Reduce filing timelines and avoid critical errors and regulatory roadblocks. Explore our comprehensive services to ensure compliance and linguistic accuracy for your global drug development and regulatory affairs needs. ...

Resource

Part 1: Clinical Trials and COVID-19: Situation now, its challenges, and the future

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect Life Sciences hosted Part 1 of the Clinical Trials and COVID-19 webinar series with industry experts to exchange ideas and provide insights into the impact of...

Resource

Part 2: Clinical Trials and COVID-19 Converting to Remote Trial Management – How to Get Started

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive hosted Part 2 of the Clinical Trials and COVID-19 webinar series with industry experts to discuss the best strategy to make the...

Resource

Part 3: Clinical Trials and COVID-19 Adapting to Rapid Change

The novel COVID-19 virus has forced a lot of rapid change in a very short period of time. Personally and professionally, we are all learning how to adapt. While restrictions on our day-today lives impact where, why, and how we interact, we still can come together as a community to learn, grown, and overcome. TransPerfect's Trial Interactive hosted Part 3 of the Clinical Trials and COVID-19 webinar series with representatives from a Sponsor and Site to discuss how they...

Resource

Part 4: Clinical Trials and COVID-19: Remote Investigator Meetings

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive presents Part 4 of the Clinical Trials and COVID-19 webinar series with industry-expert Penelope K. Manansco to discuss the best...

Resource

Driving Strategic Change: General Counsel in Pharma

TransPerfect Legal Solutions hosted a panel of GCs and legal experts from prominent pharmaceutical companies to discuss their evolving roles and the practical ways legal departments are driving innovation as it relates to people, risk, and data in the pharma industry. PANELISTS: Zafar Qadir – General Counsel, Bicycle Therapeutics Alexandra Pygall – Partner, Head of Life Sciences, Stephenson Harwood Keir LoIacano – Counsel and Vice President of Corporate Development,...

Resource

Artificial Intelligence in Life Sciences: Latest Developments Presented by Industry Leaders

Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. Our discussion will cover the following areas: - AI in drug discovery - Predicting adverse events using Natural Language Processing - Rich patient data and wearable devices - The computer...

Resource

Content Solutions for MDR & IVDR Readiness

The implementation dates for MDR (May, 2021) and IVDR (May, 2022) are fast approaching and non-compliant manufacturers are putting their EU market access at risk. These new regulatory requirements have created a “tsunami” of increased content requirements—especially in critical areas such as labeling, post-market surveillance and vigilance, software UI, marketing, and training. Manual processes and document-based systems (like Word, InDesign, and FrameMaker) simply cannot...

Resource

Enabling Diversity & Inclusion in Clinical Trials: A CRO & IRB Perspective

Diversity in clinical research is imperative to ensure the safety and effectiveness of drugs and medical devices for all people—and everyone in the industry is a key stakeholder. Clinical trials today still lack ethnic diversity, and to make trials more inclusive and improve equity in research, we ALL have a part to play. TransPerfect Life Sciences’ webinar series will take a closer look into each stakeholder’s role, current challenges, misconceptions, and activities for...

Resource

Be Where Your Patients Are: Effective Digital Strategies For Patient Recruitment

Did you know that 15–20% of studies do not launch due to unsuccessful patient enrollment? In the past, recruiting the RIGHT patient population has been complex, expensive, and challenging, especially when it comes to rare diseases or niche requirements. Join TPT Digital’s Director Brian Hansen to discuss how: - Digital marketing is an easy, inexpensive, and effective tool for patient recruitment - TPT Digital helped Amarex, a global CRO, recruit LGBTQ, HIV positive...

Resource

Shaping The Future of eCOA/ePRO

We have witnessed a rapid and dramatic migration from paper to electronic COA/PRO in the past few years. TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration technology, and setting up successful eCOA solutions....

Resource

Content Automation to Meet MDR & IVDR Requirements

Marc Miller, President of TransPerfect's Medical Device Solutions chatted with experts from Takeda Pharmaceuticals & QServe to learn about MDR & IVDR labeling compliance while cutting risk, cost, & turnaround by using structured content, process automation, & advanced AI technology....

Resource

Driving Digital Excellence: Delivering Seamless and Personalized Customer-Centric Experiences

The digital evolution in reaching and engaging with global communities, including sponsors, CROs, patients, and HCPs, has drastically shifted the way medical affairs teams connect with key stakeholders. As the industry pursues ways to improve a consumer and patient-centric approach, an omnichannel medical strategy is critical for continuing to drive collaboration, improve customer relations and patient trust, and disseminate and distribute medical information to global...

Resource

Considerations and Opportunities in Capturing Oncology Patients’ PRO Data

There has been a historic lack of guidance in capturing patient data for oncology patients. Join Bill Byrom, VP and eCOA Scientist at Signant Health in conversation with Mark Wade, Global Practice Leader at TransPerfect, as they discuss: - The need for specificity of instruments to lead to greater use of PRO data in labeling claims - The impact of the draft FDA guidance to instrument selection and COA measurement strategy - The potential of item banks and augmentation of...